BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29555471)

  • 1. Novel gadopentetic acid-doped silica nanoparticles conjugated with YPSMA-1 targeting prostate cancer for MR imaging: an in vitro study.
    Jiang W; He X; Fang H; Zhou X; Ran H; Guo D
    Biochem Biophys Res Commun; 2018 May; 499(2):202-208. PubMed ID: 29555471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
    Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
    Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
    Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
    Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
    Shao YZ; Liu LZ; Song SQ; Cao RH; Liu H; Cui CY; Li X; Bie MJ; Li L
    Contrast Media Mol Imaging; 2011; 6(2):110-8. PubMed ID: 21504064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly of SiO2/Gd-DTPA-polyethylenimine nanocomposites as magnetic resonance imaging probes.
    Luo K; Tian J; Liu G; Sun J; Xia C; Tang H; Lin L; Miao T; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z
    J Nanosci Nanotechnol; 2010 Jan; 10(1):540-8. PubMed ID: 20352889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium Nanoparticles Conjugated with Therapeutic Bifunctional Chelate as a Potential T1 Theranostic Magnetic Resonance Imaging Agent.
    Kang MK; Lee GH; Jung KH; Jung JC; Kim HK; Kim YH; Lee J; Ryeom HK; Kim TJ; Chang Y
    J Biomed Nanotechnol; 2016 May; 12(5):894-908. PubMed ID: 27305813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
    Li X; Xia S; Zhou W; Ji R; Zhan W
    Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.
    Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X
    Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
    Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
    Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
    Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
    Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocatalytic degradation of methyl red dye by silica nanoparticles.
    Badr Y; Abd El-Wahed MG; Mahmoud MA
    J Hazard Mater; 2008 Jun; 154(1-3):245-53. PubMed ID: 18055110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photo-cured PMMA/PEI core/shell nanoparticles surface-modified with Gd-DTPA for T1 MR imaging.
    Ratanajanchai M; Lee DH; Sunintaboon P; Yang SG
    J Colloid Interface Sci; 2014 Feb; 415():70-6. PubMed ID: 24267331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
    Li Q; Li C; Tong W
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
    Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
    Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general approach to prepare conjugated polymer dot embedded silica nanoparticles with a SiO2@CP@SiO2 structure for targeted HER2-positive cellular imaging.
    Geng J; Liu J; Liang J; Shi H; Liu B
    Nanoscale; 2013 Sep; 5(18):8593-601. PubMed ID: 23893174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging.
    Queiroz SM; Veriato TS; Raniero L; Castilho ML
    Radiol Phys Technol; 2024 Mar; 17(1):153-164. PubMed ID: 37991701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium(III)-Chelated Silica Nanospheres Integrating Chemotherapy and Photothermal Therapy for Cancer Treatment and Magnetic Resonance Imaging.
    Cao M; Wang P; Kou Y; Wang J; Liu J; Li Y; Li J; Wang L; Chen C
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25014-23. PubMed ID: 26418578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iridium(III) and gadolinium(III) loaded and peptide-modified silica nanoparticles for photoluminescence and magnetic resonance (dual) imaging.
    Cheng M; Zhou L; Ma J; Mu J; Yi C; Li MJ
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109972. PubMed ID: 31499999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electrochemical immunoassay for Escherichia coli O157:H7 using double functionalized Au@Pt/SiO
    Ye L; Zhao G; Dou W
    Talanta; 2018 May; 182():354-362. PubMed ID: 29501164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.